Affiliation: Children's National Medical Center
- Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology groupShana Jacobs
Children s National Medical Center, Washington, District of Columbia 20020, USA
Clin Cancer Res 16:750-4. 2010..This study aimed to determine the response rate to ixabepilone in six solid tumor strata in children and young adults...